Facts About Us

We are one of the top 20 leading pharmaceutical companies in the world.
Founded in Ingelheim 1885, Boehringer Ingelheim still remains a family-owned company.
Value through Innovation is our corporate vision, our headline goal, and has helped us build on our strength and make the most of our distinctive character.
Our mission, in the UK, is to improve the health and well being of people and animals through being part of an independent, innovative, research and development driven company.
In 2008, worldwide, we had sales of €11.6 billion; while spending one fifth of net sales in our largest business segment Prescription Medicines on research and development.
In 2008, sales in the UK were £303 million.
We have six R&D centres worldwide, the largest is based in Biberach, Germany. For more information, visit the R&D section of the corporate website.
Worldwide we have 41,300 employees; 1000 in the UK.
Our site at Bracknell is the centre for worldwide supply of sterile Unit Dose Vials, which are produced using Blow-Fill-Seal (BFS) Technology.
Our key areas of interest are: respiratory disease, cardiovascular disease, HIV, Parkinson's disease, thromboembolic disease, cerebrovascular disease and depression.
As part of our commitment to embracing economic and social well-being in the countries and communities in which we operate, we are dedicated to addressing social and environmental issues. During 2008, in the UK, we recycled a total of 1151 tons of material, including approximately 888 tonnes of plastic and 135 tons of paper and cardboard which saved around 1800 trees. This does not include the 1000 trees already planted by the company (one for each employee, to celebrate our position in the 2006 Sunday Times 100 Best Companies to Work For).
In 2008 we donated in excess of £30,000 to external charities through our Community Spirit programme.
Boehringer Ingelheim employees have chosen Samantha Dickson Brain Tumour Trust to be our Charity of the Year 2009. The trust exists to find a cure for childhood and adult Brain Tumours through funding research and to offer support, hope and information to patients and their carers.